IL6 and COVID-19: These reports extend from a hypothesized role for STAT3 in the immunopathology of COVID-19 through the IL-6 amplifier pathway, whereby STAT3 and NFκB synergize to drive inflammatory gene transcription locally in non-immune tissue, driving inflammation-mediated tissue injury [51].